1. 100 Percent Coverage of Struts and Complete Neointimal Coverage of OrbusNeich's Genous™ Bio-engineered R stent™ Demonstrated 26 Days Post-Implantation in STEMI Patient

    Explore Article PR Newswire (Aug 23 2010)

    100 Percent Coverage of Struts and Complete Neointimal Coverage of OrbusNeich's Genous™ Bio-engineered R stent™ Demonstrated 26 Days Post-Implantation in STEMI Patient SENDAI, Japan, Aug. 23 /PRNewswire/ -- OrbusNeich today reported that optical coherence tomography (OCT) evaluation of a patient with anterior ST-elevation myocardial infarction (STEMI) who received two of the company's Genous Bio-engineered R stents showed 100 percent coverage of the stent struts and complete neointimal coverage 26 days post-implantation. Stephen Wai-Luen Lee, M.B.B.S., of the Queen Mary Hospital in Hong Kong presented the findings in a presentation, "Genous Combo – The Latest of Novel Devices in the Evolution of the Coronary Intervention," as part of a symposium at the Annual Meeting of the Japanese Association of Cardiovascular Intervention and Therapeutics. ...

    Comment on Article

  2. Swiss pharmaceutical company Novartis has been given approval by EU regulators to purchase a 52 per cent stake in eye care company Alcon in addition to the 25 per cent it already owns

    Explore Article opticianonline.net (Aug 12 2010)

    Swiss pharmaceutical company Novartis has been given approval by EU regulators to purchase a 52 per cent stake in eye care company Alcon in addition to the 25 per cent it already owns Novartis will be allowed to buy the stake from current owner Nestlé after agreeing to divest several products in the ophthalmological, pharmaceutical and consumer eye care sectors in the EU. Johnson & Johnson Vision Care is supporting the Sight Care Group's 'Eye Love My Local Independent Optician' campaign to raise awareness of the benefits of independent local optical practices. Senior product manager of Johnson & Johnson Vision Care for UK and Ireland Shirley Bovonsombat said: 'Johnson & Johnson Vision Care is proud to be supporting a campaign that gives the independent sector a voice. We look forward to working with ...

    Comment on Article Mentions:   Optopol Technology

  3. iPad, iPhone app to teach St. Jude docs about intravascular OCT

    Explore Article MedCity News (Aug 11 2010)

    iPad, iPhone app to teach St. Jude docs about intravascular OCT A small online healthcare education company in Ohio is building a “highly interactive simulation” to teach doctors and radiologists at St. Jude Medical Inc. (NYSE: STJ) about optical coherence tomography (OCT). MultiWeb Communications in Rocky River just landed the job from the medical device giant in Little Canada, Minnesota, according to MultiWeb founder Karl Wilkens. St. Jude spokeswoman Kate Stoltenberg confirmed the MultiWeb project but said she could provide few details because the project is so new.

    Comment on Article Mentions:   LightLab Imaging   Marco A. Costa   Lightlab C7 XR OCT Imaging System

  4. Volcano Corporation Selects Microsoft Dynamics AX From Edgewater Fullscope

    Explore Article MarketWatch.com (Aug 10 2010)

    Volcano Corporation Selects Microsoft Dynamics AX From Edgewater Fullscope ATHENS, Ala., Aug 10, 2010 (GlobeNewswire via COMTEX) -- Today, Fullscope, Inc., a wholly-owned subsidiary of Edgewater Technology, Inc. /quotes/comstock/15*!edgw/quotes/nls/edgw (EDGW 2.74, -0.01, -0.36%) (http://www.edgewater.com) (the "Company" or "Edgewater Fullscope"), announced that Volcano Corporation, a medical device manufacturing company based in California, has selected Microsoft Dynamics AX to support company growth objectives, provide an overall lower total cost of ownership, and deliver a robust, user friendly enterprise resource planning (ERP) software for its employees. "Fullscope demonstrated that Microsoft Dynamics AX has the functionality and flexibility needed to improve performance across our rapidly growing global manufacturing operations while maintaining compliance with ...

    Comment on Article Mentions:   Volcano

  5. Research and Markets: Japanese Markets for Interventional Cardiology Devices 2009-2013

    Explore Article businesswire.com (Aug 4 2010)

    Research and Markets: Japanese Markets for Interventional Cardiology Devices 2009-2013 DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/a75bfe/japanese_markets_f) has announced the addition of the "Japanese Markets for Interventional Cardiology Devices 2009-2013" report to their offering. The Japanese interventional cardiology (IC) device market comprises the sale of coronary stents, percutaneous transluminal coronary angioplasty (PTCA) balloon catheters, accessory devices, and intravascular imaging catheters. Over the forecast period, unit sales will be driven by an increasing number of percutaneous coronary interventions (PCIs) performed to treat coronary artery disease (CAD). In 2009 and 2010, the introduction of four new drug-eluting stent (DES) brands will boost usage of premium-priced DES through 2014. In an effort to curb health ...

    Comment on Article

  6. Volcano Corporation Presentation at Canaccord Genuity Growth Conference to be Webcast

    Explore Article PR Newswire (Aug 3 2010)

    Volcano Corporation Presentation at Canaccord Genuity Growth Conference to be Webcast SAN DIEGO, Aug. 3 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating

    Comment on Article Mentions:   Axsun Technologies   Volcano   Scott Huennekens

  7. Miniature Non-MEMS Scanner For Small Size Imaging Systems

    Explore Article Photonics Online (Aug 2 2010)

    Miniature Non-MEMS Scanner For Small Size Imaging Systems The SMALLEST available non-MEMS Resonant Scanner currently on the market was developed by Electro-Optical Products Corp. is a miniature electromagnetically driven moving mirror device (0.9 x 0.5 x 0.4 inches), which deflects a light beam with a continuous sinusoidal motion. EOPC's technology offers 6 mm diameter, 7x7 mm and 12x7 mm size mirrors, with an optical scanning angle up to 50°, and a fixed-frequency scanning range from 100 to 1000 Hz, fixed at any one value within the range. AGC type driver provides: •both sine wave and TTL level square wave reference signals •trimpot control to adjust the phase of ...

    Comment on Article Mentions:   Electro-Optical Products Corporation

  8. Volcano Corporation Estimates Regulatory Approval for its OCT Cardiology System in 2011 but Potential Engineering, Regulatory, and Legal Issues Remain

    Explore Article Optical Coherence Tomography News (Jul 31 2010)

    Volcano Corporation Estimates Regulatory Approval for its OCT Cardiology System in 2011 but Potential Engineering, Regulatory, and Legal Issues Remain Volcano Corporation recently estimated that its US and European OCT regulatory approvals are expected in 2011. It seems these dates have slipped numerous times and add up to over a two and a half year delay (Late 2008 to Mid 2011) in Volcano bringing its product to this important market. While it seems that Volcano will hit its most recent expected approval dates there remain potential engineering, regulatory, and legal issues that could further delay approval - including possibly what the definition of a “tunable laser” is and where Volcano gets its “tunable laser” from. At stake an intravascular imaging ...

    Comment on Article Mentions:   LightLab Imaging   Axsun Technologies   Daniel J. Starks

  9. Interesting Options Volume for Volcano Corporation (VOLC)

    Explore Article Market Intellisearch (Jul 30 2010)

    Interesting Options Volume for Volcano Corporation (VOLC) NEW YORK (Market Intellisearch) -- Volcano Corporation options saw high put activity today. A total of 1,133 put and 17 call contracts were traded raising a high Put/Call volume alert. Today's traded Put/Call ratio is 66.65. There were 66.65 puts traded for each call contract. The ratio skew implies that investors are hedging their positions in anticipation of a stock move. Today’s unusual volume activity confirms that traders are rebalancing their portfolios. Shares of VOLC closed at $21.06 in the previous trading session and opened today at $22.93. Volcano Corporation settled the day up $1.01 to $22.07 in the trading ...

    Comment on Article Mentions:   Volcano

  10. Volcano Reports Record Quarterly Revenues and Profitability; Year-to-Date Revenues Increase 36 Percent

    Explore Article PR Newswire (Jul 30 2010)

    Volcano Reports Record Quarterly Revenues and Profitability; Year-to-Date Revenues Increase 36 Percent SAN DIEGO, July 30 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that revenues in the second quarter of 2010 increased 36 percent versus revenues in the second quarter of 2009. For the quarter ended June 30, 2010, Volcano reported record quarterly revenues of $73.5 million, compared with revenues of $54.0 million in the second quarter of fiscal 2009. For the second quarter of 2010, the company reported record net income on a GAAP basis of ...

    Comment on Article Mentions:   Axsun Technologies   Volcano   Scott Huennekens

  11. St. Jude, Volcano battle in court over FFR technology

    Explore Article Cardiovascularbusiness.com (Jul 28 2010)

    St. Jude, Volcano battle in court over FFR technology St. Jude Medical has filed a lawsuit against Volcano for patent infringement, including its PrimeWire pressure guidewire products, infringe on patents used for St. Jude’s PressureWire technology platform, which was acquired from Radi Medical Systems. In response, Volcano said it will “vigorously defend” itself against the lawsuit. The suit involves five St. Jude patents and seeks injunctive relief and monetary damages, according to the St. Paul, Minn.-based company. The PressureWire interventional technology measures fractional flow reserve (FFR).

    Comment on Article Mentions:   LightLab Imaging   Axsun Technologies   St. Jude Medical

  12. Volcano Corporation (VOLC) Stock Trades Below the 50-Day Moving Average

    Explore Article Market Intellisearch (Jul 28 2010)

    Volcano Corporation (VOLC) Stock Trades Below the 50-Day Moving Average NEW YORK (Market Intellisearch) -- Shares of Volcano Corporation settled at $21.30 down $1.19(-5.29%) in today's trading session. On the volume front, trading was heavier than usual and the price of VOLC shares crossed below the 50-day moving average of $22.37. The relationship between the stock's price and its moving average is key to determining the trend. Today's trading activity is a sign that the shares of VOLC may continue to head lower in the near future as long as the moving average continues to decrease.

    Comment on Article Mentions:   Volcano

  13. Medical Device Battle: Can St. Jude Bigfoot Volcano? (CNBC Video)

    Explore Article cnbc.com (Jul 28 2010)

    Medical Device Battle: Can St. Jude Bigfoot Volcano? (CNBC Video) This is one of those corporate battles that sometimes falls through the reporting cracks, but shouldn't. In one corner we have St. Jude Medical, the big medical device company. In the other: Volcano Corporation, which has been rapidly growing with several specialty products. Volcano's biggest product is intravascular ultrasound, which is used to help in the placement of heart stents. It's also big in something called fractional flow reserve, or FFR, which can help determine if you're going to have a heart attack and need a stent or surgery. The company’s goal is to make IVUS, as it is called, ...

    Comment on Article Mentions:   St. Jude Medical   Volcano   LightLab Imaging

  14. St. Jude Medical Files Patent Infringement Lawsuit Against Volcano Corporation in the U.S.

    Explore Article Optical Coherence Tomography News (Jul 28 2010)

    St. Jude Medical Files Patent Infringement Lawsuit Against Volcano Corporation in the U.S. ST. PAUL, Minn. St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced today that it has filed a lawsuit against Volcano Corporation for patent infringement. The suit, which involves five St. Jude Medical patents and seeks injunctive relief and monetary damages, was filed in t

    Comment on Article Mentions:   Volcano   St. Jude Medical   LightLab Imaging

  15. Volcano Will Strongly Defend Against St. Jude Lawsuit

    Explore Article PR Newswire (Jul 27 2010)

    Volcano Will Strongly Defend Against St. Jude Lawsuit SAN DIEGO, July 27 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC) stated today that it will vigorously defend against the patent infringement lawsuit filed against it by St. Jude Medical in federal district court in Delaware. Volcano believes that the claims against it are entirely without merit, and looks forward to vindicating its rights in court. The Complaint filed today has nothing to do with other litigation between the parties, including the action pending in Suffolk Superior Court in Massachusetts, in which no judgment has been entered and trial is still ongoing, and the action brought by Volcano in Delaware Chancery ...

    Comment on Article Mentions:   Axsun Technologies   St. Jude Medical   Volcano

1-15 of 334 // 1 2 3 4 ... 21 22 23 »